List view / Grid view
20 March 2019 | By Watson-Marlow Fluid Technology Group
S3 Process is using BioPure BioClamp and BioPure silicone gasket technology on its new PuroVaso containers for the effective handling of powders and tablets in life science applications...
8 March 2019 | By Nikki Withers (European Pharmaceutical Review)
The goal is to improve manufacturing flexibility, enhance quality and uniformity, while lowering the costs for patients...
5 March 2019 | By European Pharmaceutical Review
The EMA has announced that fees for new drug applications will be different from the beginning of April 2019, taking into account the rate of inflation...
4 March 2019 | By Iqra Farooq (European Pharmaceutical Review)
The pharmaceutical drug delivery market could reach $1,694.7 billion by 2023, increasing at a CAGR of 6.4 percent during the period...
1 March 2019 | By European Pharmaceutical Review
Oxford Genetics has won six new licensing deals for its scalable drug and gene therapy manufacturing in the synthetic biology sector...
27 February 2019 | By Christian Huck - Leopold-Franzens University
Strong regimentation and economic interests demand the development and implementation of new techniques for process control and analysis in the pharmaceutical industry. The extensive analysis of all deployed materials, intermediates and products leads to a higher degree of process stability and can contribute to a faster compensation for deviations, especially…
21 February 2019 | By Hyglos-bioMerieux
This article covers the analytical criteria that apply to Bacterial Endotoxin Testing (BET) using Limulus Amebocyte Lysate (LAL) or recombinant Horseshoe crab Factor C (rFC) for the bioactivity determination of endotoxin in aqueous solutions, such as pharmaceuticals and medical device extracts. It explains the importance of these criteria for accurate…
21 February 2019 | By European Pharmaceutical Review
The EU is adopting new rules which should boost the competitiveness of EU producers of generic medicines and biosimilar products...
20 February 2019 | By Eurofins CDMO
Eurofins CDMO provides a full suite of drug development services encompassing development of the bioprocesses, formulation screening, analytical development, pre-clinical testing, sterile and non-sterile bio-manufacturing of clinical trial batches and orphan drugs.
17 January 2019 | By Nikki Withers (European Pharmaceutical Review)
A generic version of the seizure drug Sabril (vigabatrin) has been approved by the FDA...
15 January 2019 | By European Pharmaceutical Review
A team of university researchers have collaborated together to develop a method to produce the radioisotope Tc-99m in the US to prevent having to import it...
10 January 2019 | By Nikki Withers (European Pharmaceutical Review)
Medical marketing increased substantially from 1997 through 2016, especially direct-to-consumer advertising for drugs and health services…
9 January 2019 | By Chun-Hang Tang, Juliet Symonds, Kevin Lief
Setting specifications for new oral products can be challenging. Too lenient, and there is a risk of passing batches of inadequate quality; too stringent, and there is a risk of rejecting acceptable batches.
8 January 2019 | By European Pharmaceutical Review
The pharma corridor between Hong Kong and Brussels Airport assures handling quality for temperature-sensitive pharmaceuticals.
7 January 2019 | By European Pharmaceutical Review
Ustekinumab has been submitted to be the first interleukin (IL)-12/23 inhibitor licensed for the treatment of ulcerative colitis...
Follow: